Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Tenax Therapeutics (TENX) Return on Sales (2016)

Tenax Therapeutics' Return on Sales history spans 6 years, with the latest figure at 2.96% for Q2 2016.

  • On a quarterly basis, Return on Sales fell 197.0% to 2.96% in Q2 2016 year-over-year; TTM through Jun 2016 was 2.96%, a 290.0% decrease, with the full-year FY2015 number at 0.7%, changed N/A from a year prior.
  • Return on Sales hit 2.96% in Q2 2016 for Tenax Therapeutics, down from 0.8% in the prior quarter.
  • Over the last five years, Return on Sales for TENX hit a ceiling of 0.03% in Q4 2012 and a floor of 2.96% in Q2 2016.
  • Historically, Return on Sales has averaged 0.61% across 4 years, with a median of 0.23% in 2012.
  • Biggest five-year swings in Return on Sales: surged 102bps in 2012 and later crashed -197bps in 2016.
  • Tracing TENX's Return on Sales over 4 years: stood at 0.03% in 2012, then tumbled by -241bps to 0.1% in 2013, then crashed by -677bps to 0.8% in 2015, then crashed by -271bps to 2.96% in 2016.
  • Business Quant data shows Return on Sales for TENX at 2.96% in Q2 2016, 0.8% in Q4 2015, and 0.18% in Q3 2015.